Cytarabine-Induced Corneal Toxicity: Clinical Features and Relief of Symptoms with Loteprednol Etabonate 0.5% in Two Patients
We report two patients who developed toxic keratopathy following high-dose cytarabine chemotherapy and whose symptoms resolved following topical loteprednol etabonate 0.5% treatment. A 25-year-old woman and a 26-year-old man with acute myeloid leukemia were referred to our department with symptoms o...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Turkish Ophthalmology Society
2021-04-01
|
| سلاسل: | Türk Oftalmoloji Dergisi |
| الموضوعات: | |
| الوصول للمادة أونلاين: |
http://www.oftalmoloji.org/archives/archive-detail/article-preview/cytarabine-nduced-corneal-toxicity-clinical-featur/47351
|
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
